Literature DB >> 30060221

The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection.

Peter Halfmann1, Lindsay Hill-Batorski1, Yoshihiro Kawaoka1,2.   

Abstract

The inflammasome is part of the innate immune system that regulates the secretion of proinflammatory cytokines such as interleukin-1β (IL-1β). Ebola virus (EBOV) infection of monocytes and macrophages (primary target cells early during infection) leads to the production of proinflammatory cytokines; however, the mechanism behind the activation and release of these cytokines is not fully understood. Here, we demonstrate that EBOV infection leads to the activation of the NLRP3 inflammasome and the subsequent secretion of IL-1β and IL-18. This process is dependent on protease caspase-1, a component of the NLRP3 inflammasome complex, but is independent of virus replication. These findings may lead to the development of novel drugs that impede the pathogenesis of EBOV infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30060221      PMCID: PMC6249561          DOI: 10.1093/infdis/jiy433

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

2.  Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation.

Authors:  Weiqiang Chen; Suan-Sin Foo; Ali Zaid; Terk-Shin Teng; Lara J Herrero; Stefan Wolf; Kothila Tharmarajah; Luan D Vu; Caryn van Vreden; Adam Taylor; Joseph R Freitas; Rachel W Li; Trent M Woodruff; Richard Gordon; David M Ojcius; Helder I Nakaya; Thirumala-Devi Kanneganti; Luke A J O'Neill; Avril A B Robertson; Nicholas J King; Andreas Suhrbier; Matthew A Cooper; Lisa F P Ng; Suresh Mahalingam
Journal:  Nat Microbiol       Date:  2017-08-28       Impact factor: 17.745

3.  Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages.

Authors:  Victoria Wahl-Jensen; Sabine K Kurz; Paul R Hazelton; Hans-Joachim Schnittler; Ute Ströher; Dennis R Burton; Heinz Feldmann
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 4.  Molecular pathogenesis of viral hemorrhagic fever.

Authors:  Christopher F Basler
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

Review 5.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

6.  Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1.

Authors:  Atsushi Okumura; Paula M Pitha; Akihiko Yoshimura; Ronald N Harty
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

7.  Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.

Authors:  Natarajan Ayithan; Steven B Bradfute; Scott M Anthony; Kelly S Stuthman; John M Dye; Sina Bavari; Mike Bray; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2013-10-08       Impact factor: 2.607

8.  NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination.

Authors:  Hong-Su Park; GuanQun Liu; Sathya N Thulasi Raman; Shelby L Landreth; Qiang Liu; Yan Zhou
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 9.  Immunological and inflammatory functions of the interleukin-1 family.

Authors:  Charles A Dinarello
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.

Authors:  Mathieu Iampietro; Patrick Younan; Andrew Nishida; Mukta Dutta; Ndongala Michel Lubaki; Rodrigo I Santos; Richard A Koup; Michael G Katze; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2017-05-22       Impact factor: 6.823

View more
  9 in total

1.  NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients.

Authors:  Vikram Thakur; Radha Kanta Ratho; Mini P Singh; Yogesh Chawla; Sunil Taneja
Journal:  Curr Microbiol       Date:  2022-01-04       Impact factor: 2.188

2.  Ebola virus glycoprotein stimulates IL-18-dependent natural killer cell responses.

Authors:  Helen R Wagstaffe; Elizabeth A Clutterbuck; Viki Bockstal; Jeroen N Stoop; Kerstin Luhn; Macaya Douoguih; Georgi Shukarev; Matthew D Snape; Andrew J Pollard; Eleanor M Riley; Martin R Goodier
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

3.  Durable natural killer cell responses after heterologous two-dose Ebola vaccination.

Authors:  Helen R Wagstaffe; Giada Susannini; Rodolphe Thiébaut; Laura Richert; Yves Lévy; Viki Bockstal; Jeroen N Stoop; Kerstin Luhn; Macaya Douoguih; Eleanor M Riley; Christine Lacabaratz; Martin R Goodier
Journal:  NPJ Vaccines       Date:  2021-01-29       Impact factor: 7.344

4.  Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome.

Authors:  Yu-Wei Chang; Ling-Chien Hung; Yu-Cheng Chen; Wen-Hung Wang; Chun-Yu Lin; Hsin-Han Tzeng; Jau-Ling Suen; Yen-Hsu Chen
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

5.  Crosstalk Between Pyroptosis and Apoptosis in Hepatitis C Virus-induced Cell Death.

Authors:  Hannah L Wallace; Lingyan Wang; Cassandra L Gardner; Christopher P Corkum; Michael D Grant; Kensuke Hirasawa; Rodney S Russell
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

6.  Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells.

Authors:  Hung Le; Paul Spearman; Stephen N Waggoner; Karnail Singh
Journal:  JCI Insight       Date:  2022-08-22

7.  Simple hypertrophic tonsils have more active innate immune and inflammatory responses than hypertrophic tonsils with recurrent inflammation in children.

Authors:  Qun Huang; Hu Hua; Wei Li; Xi Chen; Lei Cheng
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-06-01

Review 8.  The Inflammasome in Times of COVID-19.

Authors:  Juan Carlos de Rivero Vaccari; W Dalton Dietrich; Robert W Keane; Juan Pablo de Rivero Vaccari
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

Review 9.  Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.

Authors:  Lealem Gedefaw; Sami Ullah; Thomas M H Lee; Shea Ping Yip; Chien-Ling Huang
Journal:  Biomedicines       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.